Versatile DNA-Functionalized Biohybrid Hydrogel Platforms for Electrothermally Activated On-Demand Payload Release

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems

Background:

• Existing drug delivery systems lack precise control, rapid response, and high biocompatibility.
• Conventional platforms often rely on passive diffusion or biochemical triggers, limiting their efficacy.
• There is a need for advanced systems offering on-demand payload release with enhanced therapeutic outcomes.

Purpose of the Study:

• To develop an electrothermally responsive biohybrid hydrogel for on-demand payload release.
• To achieve rapid, electrically controlled drug release with high biocompatibility.
• To create a customizable platform for diverse therapeutic applications.

Main Methods:

• Incorporation of DNA-functionalized nanostructures into a biohybrid hydrogel matrix.
• Utilizing electrical stimulation to induce localized heating and trigger simultaneous DNA conformation and hydrogel structure changes.
• Evaluating the system's release kinetics, control, and biocompatibility.

Main Results:

• The developed system demonstrated rapid, electrically controlled payload release within seconds.
• The dual mechanism of altered DNA conformation and hydrogel structure facilitated on-demand release.
• The biohybrid hydrogel exhibited excellent biocompatibility, preserving cellular integrity.
• The modular DNA design allowed for easy customization via sequence modification.

Conclusions:

• The electrothermally responsive biohybrid hydrogel offers a promising platform for advanced drug delivery.
• This system overcomes limitations of conventional methods by providing precise control and rapid response.
• The customizable nature and high biocompatibility make it suitable for precision oncology, neural regulation, and wound healing.